Table:
begin	end	state
1	8	cytoplasmic
9	26	transmembrane
27	31	non-cytoplasmic
32	52	transmembrane
53	61	cytoplasmic
62	80	transmembrane
81	107	non-cytoplasmic
108	136	transmembrane
137	143	cytoplasmic
144	162	transmembrane
163	181	non-cytoplasmic
182	206	transmembrane
207	229	cytoplasmic
230	249	transmembrane
250	268	non-cytoplasmic
269	290	transmembrane
291	301	cytoplasmic
302	323	transmembrane
324	334	non-cytoplasmic
335	358	transmembrane
359	364	cytoplasmic
365	384	transmembrane
385	389	non-cytoplasmic
390	413	transmembrane
414	424	cytoplasmic
425	449	transmembrane
450	450	non-cytoplasmic

Input:
>Pf6N2E2_2863
MFGMSHETFLLLDAVVTVIGLIILITKFKFHPFIALTIAAAFLGLTSGMPTGTIIKAFQD
GFGGVLGFVGIILALGTMLGKMMAESGGADQIAQTLIRAFGKDKVQWAMMFAAFLVGIPL
FFEIGFVLLIPLVFIVARRTGVSIIKIGIPLLAGLSAVHGLVPPHPGPLLAIGIFGADIG
KTILYGLIVALPTAIIAGPIFGTFIAKHIPGHPNQELVDQLARKTDSADLPSFSITLITV
LSPVFLMLLKTFADVALPDGNLFRAWMDMIGHPISALLLALLLSLYTFGYKQGIGSSQML
KWLDASLAPTAAIILIIGAGGGFKQMLVTSGVGDVIGHMAVSAQISPILLAWLVAAVIRI
ATGSATVATITGAGIVVPVVGMMPGVNRELLVLATGAGSLILSHVNDAGFWLVKQYFNMT
VAETFKTWTAMETILSVVGLIFILLLSLVV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server